Cargando…
SPA: A Quantitation Strategy for MS Data in Patient-derived Xenograft Models
With the development of mass spectrometry (MS)-based proteomics technologies, patient-derived xenograft (PDX), which is generated from the primary tumor of a patient, is widely used for the proteome-wide analysis of cancer mechanism and biomarker identification of a drug. However, the proteomics dat...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040016/ https://www.ncbi.nlm.nih.gov/pubmed/33631430 http://dx.doi.org/10.1016/j.gpb.2019.11.016 |